3'-(4-trifluoromethyl-phenyl)-3,4,5,6-tetrahydro-2H-[1,2']bipyrazine | 1082065-32-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 3'-(4-trifluoromethyl-phenyl)-3,4,5,6-tetrahydro-2H-[1,2']bipyrazine
• 英文别名: 2-piperazin-1-yl-3-[4-(trifluoromethyl)phenyl]pyrazine
• CAS: 1082065-32-4
• 化学式: C₁₅H₁₅F₃N₄
• 分子量: 308.306
• InChiKey: RKCDCYLZWPGGIN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  41
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  3'-(4-trifluoromethyl-phenyl)-3,4,5,6-tetrahydro-2H-[1,2']bipyrazine 、 丙烯酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以55.3 %的产率得到1-(4-(3-(4-(trifluoromethyl)phenyl)pyrazin-2-yl)piperazin-1-yl)prop-2-en-1-one
  参考文献：
  名称：

  [EN] SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS
  [FR] PETITES MOLÉCULES INHIBITRICES DE MEMBRES DE LA FAMILLE TEAD (DOMAINE TEA)

  摘要：

  The present disclosure provides a compound of Formula (I): or a tautomer or pharmaceutically acceptable salt thereof, wherein Rings A, B, C, and R1and R2are defined herein, their pharmaceutical compositions, and methods of use for treating diseases that are vulnerable to inhibition of TEAD family transcription factors and/or inhibition of the pro-growth activity of the transcriptional coactivator YAP.

  公开号：

  WO2023183768A2
• 作为产物：
  描述：

  tert-butyl 4-(3-(4-(trifluoromethyl)phenyl)pyrazin-2-yl)piperazine-1-carboxylate 在 盐酸 作用下， 以 1,4-二氧六环 为溶剂， 以96.75 %的产率得到3'-(4-trifluoromethyl-phenyl)-3,4,5,6-tetrahydro-2H-[1,2']bipyrazine
  参考文献：
  名称：

  [EN] SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS
  [FR] PETITES MOLÉCULES INHIBITRICES DE MEMBRES DE LA FAMILLE TEAD (DOMAINE TEA)

  摘要：

  The present disclosure provides a compound of Formula (I): or a tautomer or pharmaceutically acceptable salt thereof, wherein Rings A, B, C, and R1and R2are defined herein, their pharmaceutical compositions, and methods of use for treating diseases that are vulnerable to inhibition of TEAD family transcription factors and/or inhibition of the pro-growth activity of the transcriptional coactivator YAP.

  公开号：

  WO2023183768A2

文献信息

• 2-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-3-PHENYL PYRAZINES AND PYRIDINES AND 3-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-2-PHENYL PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS
  申请人：Badescu Valentina O.

  公开号：US20100120785A1

  公开（公告）日：2010-05-13

  The present invention provides selective 5-HT 7 receptor antagonist compounds of Formula I and their use in the treatment of migraine, persistent pain, and anxiety: where A and B are each independently C(H)═ or N═, provided that at least one of A and B is —N═, n is 1-3, m is 0-3, and R 14 are as defined herein.

  本发明提供了5-HT7受体拮抗剂化合物I的选择性，并且这些化合物可用于治疗偏头痛、持续性疼痛和焦虑症。其中，A和B各自独立地为C(H)═或N═，但至少有一个A和B是—N═，n为1-3，m为0-3，R14如本文所定义。
• 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists
  申请人：Eli Lilly and Company

  公开号：US08202873B2

  公开（公告）日：2012-06-19

  The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine, persistent pain, and anxiety: where A and B are each independently —C(H)═ or —N═, provided that at least one of A and B is —N═, n is 1-3, m is 0-3, and R1-4 are as defined herein.

  本发明提供了式I的选择性5-HT7受体拮抗剂化合物及其在治疗偏头痛、持续性疼痛和焦虑症方面的用途：其中A和B分别独立地为—C(H)═或—N═，但至少其中之一为—N═，n为1-3，m为0-3，R1-4如本文所定义。
• WO2008/141020
  申请人：——

  公开号：——

  公开（公告）日：——
• 2-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-3-PHENYL PYRAZINES AND PYRIDINES AND 3-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-2-PHENYL PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS
  申请人：ELI LILLY AND COMPANY

  公开号：EP2155717A1

  公开（公告）日：2010-02-24
• US8202873B2
  申请人：——

  公开号：US8202873B2

  公开（公告）日：2012-06-19